Drugs / SSR411298
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01439919 | Jan → Feb 2012 | — | Sanofi | Terminated | No outcome recorded |
| Phase 2 | NCT00822744 | Dec 2008 → Feb 2010 | major depressive disorder | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SSR411298 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01439919 ↗ |
| Route | Oral | “Route: oral administration with food” NCT00822744 ↗ |